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The ability of a cell to move requires the asymmetrical
organization of cellular activities. To investigate polar-
ized cellular activity in moving endothelial cells, human
endothelial cells were incubated in a Dunn chamber to
allow migration toward vascular endothelial growth
factor. Immunofluorescent staining with a specific anti-
body against caveolin-1 revealed that caveolin-1 was
concentrated at the rear of moving cells. Similarly,
monolayer scraping to induce random cell walk resulted
in relocation of caveolin-1 to the cell rear. These results
suggest that posterior polarization of caveolin-1 is a
common feature both for chemotaxis and chemokinesis.
Dual immunofluorescent labeling showed that, during
cell spreading, caveolin-1 was compacted in the cell cen-
ter and excluded from nascent focal contacts along the
circular lamellipodium, as revealed by integrin 1 and
FAK staining. When cells were migrating, integrin 1
and FAK appeared at polarized lamellipodia, whereas
caveolin-1 was found at the posterior of moving cells.
Notably, wherever caveolin-1 was polarized, there was a
conspicuous absence of lamellipod protrusion. Trans-
mission electron microscopy showed that caveolae, sim-
ilar to their marker caveolin-1, were located at the cell
center during cell spreading or at the cell rear during
cell migration. In contrast to its unphosphorylated form,
tyrosine-phosphorylated caveolin-1, upon fibronectin
stimulation, was associated with the focal complex mol-
ecule phosphopaxillin along the lamellipodia of moving
cells. Thus, unphosphorylated and phosphorylated
caveolin-1 were located at opposite poles during cell
migration. Importantly, loss of caveolin-1 polarity by
targeted down-regulation of the protein prevented cell
polarization and directional movement. Our present re-
sults suggest a potential role of caveolin polarity in la-
mellipod extension and cell migration.
Endothelial cell migration is a key step toward angiogenesis,
a process that is required in a variety of physiological and
pathological conditions, such as embryonic development,
wound healing, tissue regeneration, and tumor growth and
metastasis. A clear understanding of how endothelial cells
sense chemoattractants, organize signaling asymmetry, and
make a directional movement is of pivotal importance in the
biology of normal cells, as well as tumor angiogenesis. Like
other types of crawling cells, migrating endothelial cells ac-
quire a series of spatially polarized features. The front of a
migrating cell generates protrusive force associated with la-
mellipod or filopod protrusion coupled with the development of
new cell adhesions to the extracellular substrates. Cell contrac-
tility is required to allow the retraction of the body and rear of
the cell. Apart from the surface features, such as lamellipodia
and microspikes, relatively little is known about the “direc-
tional sensing” machinery that orients locomotion machinery
in endothelial cells.
Caveolae (also termed plasmalemmal vesicles) are special-
ized microdomains on the plasma membrane with a size of
50–100 nm (1). In addition to transcytosis and endocytosis, a
good body of evidence has shown that caveolae compartmen-
talize and integrate signaling events at the cell surface (2–4). A
variety of protein and lipid signaling molecules involved in
VEGF1 receptor and integrin-mediated signaling are concen-
trated in caveolae. These include VEGF-R2 (KDR), non-recep-
tor tyrosine kinases (such as Src, Yes, and Fyn), PI 3-kinase,
Rac1, Cdc42, and RhoA, and phosphatidylinositol (4–9). These
observations suggest a potential role of caveolae in mediating
signal transduction involved in cell migration.
The major structural proteins of caveolae are the caveolins.
Four caveolins encoded by three different genes have been
identified. Endothelial cells abundantly express caveolin-1 and
-2 (but not caveolin-3, which is muscle-specific) (10). Caveolin-1
interacts with a number of signaling proteins, including Src
family kinases, G subunits, H-Ras, protein kinase C, endothe-
lial nitric-oxide synthase, PI 3-kinase, integrins, and epidermal
growth factor receptor (11–14). In general, interaction between
caveolin via the caveolin scaffolding domain and signaling pro-
teins leads to inactivation of the target proteins (11). Thus,
caveolin may function as an endogenous negative regulator of
many signaling molecules. Given this view, one would predict
that down-regulation of caveolins may lead to an increase in
basal activity of signaling pathways and subsequent cellular
activity, such as cell motility. In accordance with this, an at-
tractive hypothesis would be that mere translocation of caveo-
lin (i.e. caveolin polarization), without a substantial change in
the expression level, would reinforce an inhibitory effect on one
part of the cell (i.e. the cell rear) but release its inhibitory
activity on the other side (i.e. the leading edge). This hypothesis
is supported by recent studies showing caveolae and caveolin-1
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asymmetry during cell migration (15–18). However, whether
caveolin-1 polarity affects endothelial cell lamellipod protru-
sion and migration is not known.
In the present study, we demonstrated that caveolin-1 and
caveolae were excluded from the leading edge and directed
toward the rear of migrating cells. Interestingly, a subpopula-
tion of caveolin-1 that was phosphorylated on tyrosine 14 spe-
cifically moved to focal adhesions at the leading edge of migrat-
ing cells. Importantly, loss of caveolin-1 polarity by targeted
knockdown of the protein prevented endothelial cell polariza-
tion and impeded cell directional movement.
EXPERIMENTAL PROCEDURES
Materials—Reagents and other supplies were obtained from the fol-
lowing commercial sources: antibodies against caveolin-1, phospho-
caveolin-1, and FAK from BD Biosciences (San Diego, CA). Phalloidin-
TRITC and fibronectin were purchased from Sigma. Antibodies against
integrin 1, green fluorescent protein, and c-Myc were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Goat serum, fluorescein
isothiocyanate, and Rhodamine Red-X-conjugated secondary antibodies
were obtained from Jackson Immuno-Research Laboratories (West
Grove, PA). Antibodies against paxillin, phosphopaxillin (pTyr-31), and
phospho-FAK (pTyr-397) were obtained from BIOSOURCE Interna-
tional (Camarillo, CA). Slow-Fade reagent was purchased from Molec-
ular Probes (Eugene, OR). The bicinchoninic acid protein assay kit was
purchased from Pierce (Rockford, IL).
Cell Culture—Primary cultured endothelial cells from the human
umbilical vein (HUVECs) were obtained as described previously (19)
from consenting healthy, term patients according to institutional guide-
lines. HUVECs were grown in Medium 199 supplemented with 5%
heat-inactivated human serum, 20% heat-inactivated newborn calf se-
rum and endothelial cell growth supplement.
Construction of siRNA—The sequence (AAGAGCTTCCTGATT-
GAGATT) was selected as the targeting region of caveolin-1, which
corresponds to nucleotides 403–423 of the coding region of human
caveolin-1 (GenBankTM accession number BC009685). Caveolin-1
siRNA primers (5-AATCTCAATCAGGAAGCTCTT-3 and 5-GAGCT-
TCCTGATTGAGATTTT-3) were used for synthesis of double-stranded
RNA (dsRNA) by Qiagen (Valencia, CA). Control siRNA was also ob-
tained from Qiagen. The target sequence of the control siRNA was the
DNA sequence AATTCTCCGAACGTGTCACGT, which contains a 16-
base overlap with Thermotoga maritimia (GenBankTM accession num-
ber AE001709) section 21 of 136 of the complete genome, with no other
BLAST matches. The level of caveolin-1 expression was determined by
Western blot analysis and immunocytochemistry using specific anti-
body against caveolin-1. The specific down-regulation of caveolin-1 ex-
pression by caveolin-1 siRNA was assessed using control siRNA.
Transfection of Endothelial Cells with siRNA—Endothelial cells
were seeded at a density of 6  104 cells/well in a 6-well plate 24 h prior
to transfection. For each transfection, 1.0 g of dsRNA was diluted into
200 l of serum-free medium in a tube. In another tube, 6 l of Oligo-
fectamine (Invitrogen) were mixed with 54 l of serum-free medium.
The two solutions were combined, mixed gently, and incubated for 30
min at room temperature followed by the addition of 400 l of serum-
free medium. The cells were washed once with serum-free medium and
incubated with dsRNA mixtures or Oligofectamine medium (mock
transfection) for 4 h at 37 °C in a humidified CO2 incubator. At the end
of incubation, 2 ml of growth medium were added to each well, and the
cells were incubated for 20 h. The medium was replaced with growth
medium 24 h after transfection. Forty-eight h post-transfection (which
resulted in an 80% reduction in caveolin-1 level), the cells were used
for a migration assay.
Scratch Motility Assay—Confluent endothelial cells were wounded
by scraping of the monolayer with a 200-l pipette tip (20). Cultures
were washed once with phosphate-buffered saline and incubated with
growth medium. The cells were incubated at 37 °C for 10 h to allow
migration toward the gap and then fixed, permeabilized, and stained for
caveolin-1.
Dunn Chamber Assay—Endothelial cells were seeded on fibronectin-
coated coverslips and starved for 24 h prior to assay. To set up gradient
experiments, both concentric wells of the chamber were filled with
starvation medium (medium 199 with 0.5% fetal bovine serum), and a
coverslip seeded with cells was inverted onto the chamber in an offset
position leaving a narrow slit at one edge for refilling the outer well. The
coverslip was sealed in place using hot wax mixture around all the
edges except for the filling slit. The medium of the outer well was
drained and replaced with medium containing 0.5% fetal bovine serum
and 10 ng/ml VEGF. The slit was then sealed with hot wax mixture.
When the inner circular well of the chamber was filled with control
medium and the outer annular well with medium containing chemoat-
tractant, a radially directed linear diffusion gradient was established in
the diffusion gap within 10–30 min, which had a half-life of 10–30 h
(21). For control experiments in which cells were subjected to uniform
concentrations of chemoattractant, both wells were filled with medium
containing VEGF (10 ng/ml). At the end of each migration assay, the
coverslip was carefully removed from the Dunn chamber, and the cells
were processed for immunocytochemistry analysis.
Immunocytochemistry—Endothelial cells were fixed with 2%
paraformaldehyde for 20 min, permeabilized with 1% Triton X-100,
blocked with 5% goat serum, and stained with specific antibody against
caveolin-1 or other signaling molecules. Bound primary antibodies were
detected using fluorescein- or rhodamine-conjugated secondary anti-
bodies. The immunostained cells were mounted in the presence of
Slow-Fade reagent. Immunostaining was visualized and photographed
using a Zeiss LSM 510 confocal microscope.
Immunoblot Analysis—Proteins of the subcellular fractions were solu-
bilized with SDS sample buffer containing 0.125 M Tris-HCl (pH 6.8), 5%
(w/v) SDS, 2.5% (v/v) -mercaptoethanol, 5% glycerol in double-distilled
water. After boiling for 4 min, proteins were separated by SDS-PAGE
(5–15% gradient gels) and electro-transferred to a nitrocellulose mem-
brane for immunoblotting using enhanced chemiluminescence.
Transmission Electron Microscopy—Endothelial cells were either
sparsely seeded onto gelatin-coated plates for 1 h or seeded near con-
fluence, scratched multiply with a 200-l pipette tip, and incubated to
allow cell migration. The cells were then fixed with 2.5% glutaralde-
hyde in 0.1 M phosphate buffer and scraped into a microcentrifuge tube.
The cells were pelleted and post-fixed with osmium tetroxide. After
fixation, the cells were infiltrated with a propylene oxide/epon mixture
and stained with uranyl acetate and lead citrate. Thin sections of
samples were examined under a JEOL 1220 transmission electron
microscope. On randomly taken photographs, the number of caveolae at
the leading edge and the cell center of spreading cells or at the leading
edge and the cell posterior of migrating cells was determined.
RESULTS
Caveolin-1 Is Located at the Rear of Migrating Cells—Previ-
ous studies have shown that caveolin-1 displays polarization in
migrating cells. For instance, caveolin-1 accumulated at the
trailing edge of scratch-induced migrating bovine aortic endo-
thelial cells or shear stress-stimulated bovine aortic endothe-
lial cells (15, 16). On the other hand, caveolin-1 was concen-
trated at the leading edge of fibroblast growth factor-
stimulated migrating bovine aortic endothelial cells (16). To
assess whether the discrepancy of caveolin-1 polarization re-
sulted from chemotactic gradient, we employed two kinds of
cell migration systems: chemokinesis to measure random walk
using monolayer denudation (also termed scratch motility assay)
and chemotaxis to measure directional movement using the
Dunn chamber. Six hours after scraping, the endothelial cells
began to migrate into the wound gap. The closure of wound gaps
took 24 h. Immunofluorescent staining with a specific antibody
against caveolin-1 showed that the majority of caveolin-1 was
located at the rear of most moving cells (Fig. 1, b and c, green
arrowheads) opposite the lamellipodium of the leading edge (Fig.
1c, green arrows). Similarly, when cells were exposed to a linear
gradient of VEGF, caveolin-1 was concentrated at the rear or
trailing edge of moving cells (Fig. 1d, green arrowheads). These
results indicate that caveolin-1 polarization at the cell posterior
is a common feature of both directional and random movements.
Mutual Exclusion Between Caveolin-1 and Focal Contacts at
the Leading Edge—The migration-activated posterior reloca-
tion of caveolin-1 is intriguing and suggests that when cells are
stimulated to migrate, caveolin-1 (along with caveolae; see Fig.
3) moves to the rear of the migrating cell as a mechanism to
sequester it away from signaling proteins that direct cell mo-
tility at the leading edge. Here, we focused on nascent focal
adhesions at the leading edge revealed by immunostaining
with specific antibody against integrin 1 and FAK. Human
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umbilical vein endothelial cells were seeded on fibronectin-
coated coverslips. Within 1 h after seeding, most cells spread
radially. As shown in Fig. 2, caveolin-1 was localized compactly
in the center of the spreading cells (Fig. 2, a and g) and was
excluded from nascent focal contacts along the circular lamel-
lipodium revealed by FAK or integrin 1 staining (Fig. 2, b and
h). After incubation for several hours, focal contacts appeared in
the polarized lamellipodia at the leading edge of migrating cells
(Fig. 2, e and k). Caveolin-1 signal was now relocated at the rear
of most moving cells (Fig. 2, d and j). These data confirm that
caveolin-1 moves to the opposite pole of a migrating cell,
compared with FAK and 1 integrin at the leading edge.
Exclusion of Caveolae from Lamellipodia—Like many other
terminally differentiated cells, such as adipocytes, fibroblasts,
and skeletal muscle cells, endothelial cells possess a large
number of caveolae (1, 22). Rapid freeze, deep etch images show
that caveolae have a striated coat and contain the integral
22-kDa membrane protein, caveolin (23). The coat protein is a
reliable marker for tracing caveolae trafficking in live cells (24).
Based on our results described above demonstrating that
caveolin-1 was centrally concentrated in spreading cells, we
predicted that caveolae may be centrally localized as well. To
assess the location of caveolae, endothelial cells were seeded for
1 h to allow spreading and then fixed and processed for electron
microscopy analysis. As shown in Fig. 3, caveolae were local-
ized abundantly at the cell center of spreading cells (Fig. 3A, b,
arrowheads; Fig. 3B). Few, if any, caveolae were found at the
lamellipod protrusion (Fig. 3B). When cells were migrating,
caveolae, like their marker caveolin-1, were now concentrated
at the cell rear (Fig. 3A, d, arrowheads; Fig. 3C), opposite the
lamellipodium. In contrast, few, if any, caveolae were found at
the leading edge of migrating cells (Fig. 3A, e; Fig. 3C). Again,
these results indicate that caveolae, along with caveolin-1,
were excluded from the leading edge of migrating cells.
Phosphocaveolin-1 Is Co-localized with Focal Complex Mole-
cules at the Leading Edge of Migrating Cells—Caveolin is one
of the major v-Src substrates in Rous sarcoma virus-trans-
formed chicken embryo fibroblasts (25). Stimulation of A431
cells with EGF or NIH 3T3 cells with hyperosmotic stress leads
to phosphorylation of caveolin-1 on tyrosine 14, and the phos-
phorylation events are associated with focal adhesions (26, 27).
To assess whether phosphorylation of caveolin-1 occurred and
where the phosphorylation took place during cell migration,
endothelial cells were treated with fibronectin and dually
stained with specific antibodies against phosphocaveolin-1 and
either phosphopaxillin or caveolin-1. Dual immunolabeling re-
vealed that phosphocaveolin-1 co-localized with the focal adhe-
sion marker, phosphopaxillin, at the leading edge of migrating
cells (Fig. 4, a–c), indicating that caveolin-1 was associated
with focal complexes along the lamellipodium concomitant with
tyrosine 14 phosphorylation. In contrast, a significant popula-
tion of caveolin-1 that was not immunoreactive with Tyr-14
phosphospecific antibodies localized to the rear of migrating
cells (Fig. 4, e and f). These data indicate that when tyrosine-
phosphorylated, caveolin-1 associated with focal complex mol-
ecules at the leading edge of a migrating cell.
Targeted Knockdown of Caveolin-1 Impedes Cell Polarity—
Our results demonstrated that caveolin-1 was directed to the
posterior of either directionally or randomly moving cells, sug-
gesting that caveolin-1 may play an important role in cell
movement. We reasoned that during migration, caveolin-1 to-
gether with caveolae move to the rear of a migrating cell as a
mechanism to sequester it away from signaling proteins that
direct cell motility at the leading edge and that loss of caveo-
lin-1 asymmetry by down-regulation of the protein would im-
pede cell polarity and hence, cell migration. To test this hy-
pothesis, we employed RNA interference to knock down
caveolin-1 and examine its effect on cell polarity and migration.
HUVECs were transfected with either caveolin-1 siRNA or
control siRNA for 48 h and then seeded on fibronectin and
incubated to allow migration. As shown in Fig. 5C, transfection
with caveolin-1 siRNA specifically knocked down caveolin-1
FIG. 1. Caveolin-1 polarization during cell migration. Confluent HUVECs were either cultured on coverslips (a) or wounded by scraping
the monolayer with a pipette tip (b), incubated for 10 h to allow migration toward the gap (red arrow in b), and then fixed and immunostained with
antibody for caveolin-1 (a and b) or dually stained with caveolin-1 (fluorescein isothiocyanate) and integrin 1 (Rhodamine Red-X) (c) to reveal the
leading edge of a migrating cell. Note that when cells migrated toward the wound gap, caveolin-1 was relocated to the rear of moving cells (green
arrowheads in b and c) opposite the lamellipodia (green arrows in c). Dunn chamber assay (d and e). HUVECs were seeded on coverslips pre-coated
with fibronectin and incubated at 37 °C to allow migration toward VEGF (red arrow in d) until they appeared in the bridge and outer well of the
chamber (see “Experimental Procedures”). At that time, the coverslips were removed from the chamber, and the cells were fixed and subjected to
dually immunofluorescent staining with specific antibody for caveolin-1 (fluorescein isothiocyanate, d) and integrin 1 (Rhodamine Red-X, e). Note
that caveolin-1 signal was again localized at the rear and trailing edge of moving cells (green arrowheads in d and e) opposite the leading edge (green
arrows in e).
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levels by 80%. Notably, knockdown of caveolin-1 dramatically
impeded the ability of endothelial cells to polarize, which in-
stead maintained a near-circular lamellipodium (Fig. 5A, b),
whereas control siRNA- or mock-treated cells were able to
polarize as normal (Fig. 5A, a and c). A comparison of Cav-1
siRNA-treated with control siRNA- or mock-treated cells re-
vealed a significant reversal of the ratio of circular to polarized
cells in the Cav-1 siRNA group, with caveolin-1 knockdown
inhibiting the polarization of endothelial cells (Fig. 5B).
Knockdown of Caveolin-1 Inhibits Endothelial Cell Direc-
tional Movement—Given the nature of caveolin-1 as a scaffold-
ing protein to organize and sequester signaling molecules,
caveolin-1 may coordinate cellular activities between the lead-
ing edge and rear of a moving cell. In response to environmen-
tal stimulation, cells exclude caveolin-1 from the leading edge
by an unknown mechanism and eliminate its inhibitory ac-
tion on signaling molecules that are involved in lamellipod
protrusion. At the same time, caveolin-1 concentrates and
reinforces its inhibitory action at the posterior of a polarized
cell. Hence, a cell may sense and move directionally by ex-
clusion of caveolin-1 from the leading edge. In accordance
with this, loss of caveolin polarity would inhibit directional
cell movement. To test this hypothesis, HUVECs were trans-
fected with caveolin-1 siRNA and subjected to chemotactic
response to serum using a well characterized microchemo-
taxis chamber system (28). As shown in Fig. 6, loss of
caveolin-1 polarity by knockdown of the protein dramatically
reduced the number of migrating endothelial cells by 3-fold
over mock or control siRNA-treated cells. Thus, our results
indicate that loss of caveolin-1 asymmetry impeded
endothelial cell directional movement.
DISCUSSION
We have demonstrated that caveolin and caveolae polarized
regardless of VEGF-induced directional movement or mono-
layer scraping-induced random walk. Polarization was found at
the rear of moving cells in both models. Notably, during cell
spreading or migration, extension of the leading edge and pro-
trusion of lamellipodia were not observed in the area with
higher caveolin-1 signal. Although caveolin has an intimate
relationship with the cytoskeleton, little is known about the
function of the protein in cell migration. In the present study,
we have shown that loss of caveolin polarity by knockdown of
the protein dramatically inhibited cell polarization and im-
peded cell directional movement. Our results indicate an es-
sential role of caveolin polarity in lamellipod protrusion and in
orienting directional movement in endothelial cells. Fig. 7 de-
picts a model of cell polarization in which caveolin-1 is located
at the rear of a moving cell, where it prevents lamellipod
protrusion. Upon phosphorylation at tyrosine 14, caveolin-1 is
released from caveolae and associated with focal adhesion sites
at the leading edge, where it may mediate the recruitment of
Csk and affect the formation of focal adhesions (29).
Our present results are consistent with previous reports
demonstrating caveolin and caveolae polarization in bovine
aortic endothelial cells in response to shear stress (15), mono-
layer scraping, or fibroblast growth factor stimulation (16). Our
result of growth factor-induced caveolin relocation at the cell
posterior stands in contrast to a recent report that caveolin is
located to the leading edge of fibroblast growth factor-stimu-
lated transmigrating bovine aortic endothelial cells (16). Inter-
estingly, the leading edge accumulation of caveolin-1 requires
FIG. 2. Mutual exclusion between
caveolin-1 and focal contacts at the
leading edge. HUVECs were seeded on
fibronectin-coated coverslips and incu-
bated at 37 °C either for cell spreading
assay or cell migration assay. After incu-
bation, the cells were fixed, permeabi-
lized, and subjected to dual immunofluo-
rescent staining with caveolin-1 (a, d, g,
and j) and either FAK (b and e) or integrin
1 (h and k). Composite images (c, f, i, and
l) resulting from the superimposition of
caveolin-1 signal and FAK or integrin 1
are shown. Note that during cell spread-
ing, caveolin-1 was excluded from nascent
focal contacts, revealed by FAK and inte-
grin 1 staining along the leading edge
and located compactly in the cell center.
When cells were migrating, focal contacts
localized to one or sometimes two polar-
ized lamellipodia, whereas caveolin-1 ap-
peared at the body and rear of moving
cells.
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phosphorylation of the protein at tyrosine 14, which is consist-
ent with our finding that tyrosine-phosphorylated endogenous
caveolin-1 associated with focal adhesion molecules at the lead-
ing edge (see Fig. 4). This study did not determine whether the
polarized endogenous caveolin-1 is tyrosine-phosphorylated;
therefore, it is not clear whether they were observing forward
relocation of non-phosphorylated or phosphorylated caveolin-1.
Manes et al. (30) showed recently the relocation of lipid rafts to
the leading edge of insulin-like growth factor-I-stimulated
MCF-7 denocarcinoma cells. Because the study did not exam-
ine the location of caveolin-1, a marker of caveolae, it is unclear
that the relocation of lipid rafts represents caveolae or non-
caveolae rafts. Thus, caveolin and caveolae relocation depends
on the modes of cell migration and is cell-type-specific. None-
theless, the observation that different stimulations lead to
caveolin and caveolae relocation suggests that it is a general
mechanism for cells to spatially organize subcellular activities
that direct cell motility.
The majority of caveolin-1 is found at the cell surface and
associated with caveolae (23, 31). Some Golgi-associated caveo-
lin-1 is in transit from its site of synthesis in the endoplasmic
reticulum to the cell surface (32). The recycling of surface
caveolin-1 through the Golgi apparatus involves the directional
movement of the molecule from caveolae to the lumen of the
endoplasmic reticulum and onto the Golgi apparatus (33, 34).
One possible mechanism that directs caveolae and caveolin-1
polarization is that recycling caveolar vesicles accumulate at
the cell rear during migration. Another possibility is that
caveolin-1 and caveolae accumulate at the cell posterior as a
result of differential movement of other organelles. The exper-
imental observation that cell polarization signals are upstream
and independent of those triggering cell motility suggests that
microscopy. During cell spreading, caveolae were centrally located (ar-
rowheads in b) in proximity to the nucleus (N) and excluded from
lamellipodia. When cells were migrating, caveolae were found to be
concentrated in the rear of the cells (arrowheads in d) opposite the
lamellipodia (e). Scale bars, 0.2 m in B; 0.5 m in d and e. The number
of caveolae at the leading edge and cell center of spreading cells (B) and
at the leading edge and cell posterior of migrating cells (C) was deter-
mined by counting caveolae in randomly taken photographs. Data are
the means  S.D. from ten photographs.
FIG. 3. Exclusion of caveolae from lamellipodia. Endothelial
cells were seeded for 1 h to allow spreading (a in A), or a confluent
monolayer was scraped to induce cell migration (c in A). After incuba-
tion, the cells were fixed and processed for transmission electron
FIG. 4. Co-localization of phosphocaveolin-1 with focal com-
plex molecules at leading edge of migrating cells. HUVECs were
seeded on fibronectin-coated coverslips and incubated to allow migra-
tion. After incubation, the cells were fixed and stained with specific
antibodies against phosphocaveolin-1 (pCav-1) (a and d), phosphopax-
illin (pPax) (b), or Cav-1 (e). Composite images (c and f) resulting from
the superimposition of pCav-1 signal and pPax or Cav-1 reveal a sig-
nificant co-localization of pCav-1 with pPax (c) at focal complexes. In
contrast, Cav-1 was concentrated in the body and rear of migrating cells
opposite pCav-1 at the leading edge (f).
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asymmetric caveolin redistribution is not the consequence of
cell movement (35, 36).
Caveolin-1 was first identified as a major tyrosine-phospho-
rylated protein in v-Src-transformed chicken embryo fibro-
blasts (25). Microsequencing of Src-phosphorylated caveolin-1
revealed that phosphorylation occurs within the extreme N-
terminal region of the full-length of caveolin-1 (37). Site-di-
rected mutagenesis showed that tyrosine 14 is the principal
substrate for Src kinase (37). Recent studies have shown that
caveolin-1 undergoes phosphorylation at tyrosine 14 in re-
sponse to a number of stimulations, such as insulin, EGF, and
osmotic stress. Tyrosine-phosphorylated caveolin-1 provides a
docking site recruiting SH2 domain-containing proteins, such
as Grb7 and Csk, and augments EGF-stimulated cell migration
(26, 29). Because Grb7 contains an SH2 domain and a phos-
photyrosine-interacting region (38), it may function as a bridge
linking phosphorylated caveolin-1 to other tyrosine-phosphory-
lated proteins, such as FAK (39). In the present study, we
observed a rapid phosphorylation of caveolin-1 at tyrosine 14
upon fibronectin stimulation. Importantly, unlike the unphos-
phorylated caveolin-1, tyrosine-phosphorylated caveolin-1 was
co-localized with focal complex molecules at the leading edge of
migrating cells. The discovery that tyrosine-phosphorylated
caveolin-1 and unphosphorylated caveolin-1 polarize at two
opposing poles of moving cells is intriguing, although the mech-
FIG. 5. Knockdown of caveolin-1
prevents endothelial cell polariza-
tion. HUVECs were transfected with ei-
ther caveolin-1 siRNA or control siRNA,
as described under “Experimental Proce-
dures.” A, forty-eight hours after transfec-
tion, HUVECs were seeded on fibronec-
tin, incubated to allow migration, fixed,
and then subjected to dual immunofluo-
rescent staining with specific antibody for
caveolin-1 (fluorescein isothiocyanate) or
paxillin (Rhodamine Red-X). Note that
mock- and control siRNA-treated cells
were able to polarize (a and c). In con-
trast, knockdown of caveolin-1 impeded
polarization of the cells (b), which instead
displayed a near-circular lamellipodium.
B, the effect of caveolin-1 knockdown on
cell polarization was quantified by count-
ing circular versus polarized cells from
eight randomly selected views corre-
sponding to each of the treatments. Data
are the means  S.D. C, caveolin-1 pro-
tein levels were specifically knocked down
by the caveolin-1-specific siRNA.
FIG. 6. Knockdown of caveolin-1 inhibits endothelial cell di-
rectional movement. HUVECs were transfected with either caveolin-
1-specific or control siRNA or alternately were mock transfected. Forty-
eight h after transfection, the cells were placed over a polycarbonate
filter and allowed to migrate through 8-m pores to an adjacent com-
partment in response to serum stimulation. After a 3-h incubation, the
cells that migrated to the serum compartment were counted. Note that
knockdown of caveolin-1 dramatically inhibited cell migration com-
pared with control siRNA- or mock-treated cells. Data are
means  S.D.
FIG. 7. Proposed model demonstrating caveolin-1 polarity and
control of lamellipod protrusion. Caveolin-1, the integral mem-
brane protein of caveolae, is believed to interact with signaling mole-
cules. Immunofluorescent staining of a resting cell (left) with antibody
for caveolin-1 reveals a punctate staining pattern at the cell surface
(small dots, left). Upon chemotactic stimulation (right), caveolin-1 is
excluded from the leading edge and relocates to the cell posterior (small
dots, right) where it prevents lamellipod protrusion (T bar, right). In
contrast, tyrosine-phosphorylated caveolin-1 is separated from caveolae
and associated with focal complexes (Int/FAK) at the leading edge
(small crosses, right). Thus, caveolin-1 polarity may serve to spatially
organize cellular activity that mediates lamellipod protrusion. Loss of
caveolin-1 polarity by targeted knockdown of the protein impedes cell
polarization.
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anism underlying this is unclear. Therefore, during cell migra-
tion, phosphorylated caveolin-1 located at focal complexes
along the leading edge might couple integrin to non-receptor
tyrosine kinases, such as Src, Fyn, and FAK, whereas unphos-
phorylated inhibitory caveolin-1 is relocated to the cell rear.
Our present results demonstrated that loss of caveolin po-
larity impede endothelial cell polarity and directional move-
ment and suggest that caveolin may play an important role in
angiogenesis. This idea is supported by a variety of studies
showing that caveolin-1 affects capillary formation. We and
others have shown recently that antisense-mediated down-
regulation of caveolin-1 inhibits capillary tubule formation (40,
41). Up-regulation of caveolin-1 in microvascular endothelial
cells enhances capillary tubule formation via the caveolin-1
scaffolding domain (41). The importance of caveolin-1 in angio-
genesis is further emphasized by a recent study demonstrating
a reduced infiltration of blood vessels into fibroblast growth
factor-supplemented Matrigel plugs in caveolin-1 knock-out
mice (42). In the same mice, tumor weight, volume, and blood
vessel density are reduced due to lack of caveolin-1 and
caveolae (42).
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